Lan T - Search Results

1

CCL5/CCR5 axis in human diseases and related treatments.

Zeng Z, Lan T, Wei Y, Wei X. Zeng Z, et al. Among authors: lan t. Genes Dis. 2022 Jan;9(1):12-27. doi: 10.1016/j.gendis.2021.08.004. Epub 2021 Aug 26. Genes Dis. 2022. PMID: 34514075 Free PMC article. Review.

2

Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy.

Lan T, Chen L, Wei X. Lan T, et al. Cells. 2021 Jan 8;10(1):100. doi: 10.3390/cells10010100. Cells. 2021. PMID: 33429846 Free PMC article. Review.

3

Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma.

Liu X, Lan T, Mo F, Yang J, Wei Y, Wei X. Liu X, et al. Among authors: lan t. Front Cell Dev Biol. 2021 May 26;9:689613. doi: 10.3389/fcell.2021.689613. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34124076 Free PMC article.

4

Crystalline silica induces macrophage necrosis and causes subsequent acute pulmonary neutrophilic inflammation.

Nie W, Lan T, Yuan X, Luo M, Shen G, Yu J, Wei X. Nie W, et al. Among authors: lan t. Cell Biol Toxicol. 2022 Aug;38(4):591-609. doi: 10.1007/s10565-021-09620-1. Epub 2021 Jun 25. Cell Biol Toxicol. 2022. PMID: 34170461

5

Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response.

Wan D, Que H, Chen L, Lan T, Hong W, He C, Yang J, Wei Y, Wei X. Wan D, et al. Among authors: lan t. Nano Lett. 2021 Oct 13;21(19):7960-7969. doi: 10.1021/acs.nanolett.1c01968. Epub 2021 Sep 17. Nano Lett. 2021. PMID: 34533963 Free article.

6

Mesenchymal stem/stromal cells in cancer therapy.

Lan T, Luo M, Wei X. Lan T, et al. J Hematol Oncol. 2021 Nov 17;14(1):195. doi: 10.1186/s13045-021-01208-w. J Hematol Oncol. 2021. PMID: 34789315 Free PMC article. Review.

7

Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles?

Lan T, Wei X. Lan T, et al. Mol Biomed. 2021 May 20;2(1):14. doi: 10.1186/s43556-020-00025-w. Mol Biomed. 2021. PMID: 35006447 Free PMC article. No abstract available.

8

Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy.

Lan T, Que H, Luo M, Zhao X, Wei X. Lan T, et al. Mol Cancer. 2022 Mar 11;21(1):71. doi: 10.1186/s12943-022-01550-8. Mol Cancer. 2022. PMID: 35277177 Free PMC article. Review.

9

SARS-CoV-2 Omicron variant: Immune escape and vaccine development.

Ao D, Lan T, He X, Liu J, Chen L, Baptista-Hon DT, Zhang K, Wei X. Ao D, et al. Among authors: lan t. MedComm (2020). 2022 Mar 16;3(1):e126. doi: 10.1002/mco2.126. eCollection 2022 Mar. MedComm (2020). 2022. PMID: 35317190 Free PMC article. Review.

10

CXCL13 as a Novel Immune Checkpoint for Regulatory B Cells and Its Role in Tumor Metastasis.

Ren J, Lan T, Liu T, Liu Y, Shao B, Men K, Ma Y, Liang X, Wei YQ, Luo M, Wei XW. Ren J, et al. Among authors: lan t. J Immunol. 2022 May 15;208(10):2425-2435. doi: 10.4049/jimmunol.2100341. Epub 2022 Apr 18. J Immunol. 2022. PMID: 35437281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,821 results

Search Page